Lyon Street Capital’s Neos Therapeutics NEOS Stock Holding History
Bought
Maintained
Sold
Other funds holding NEOS
Lyon Street Capital's NEOS Position: Q4 2018 in Review
Lyon Street Capital sold out of Neos Therapeutics (NEOS) in Q4 2018, closing a stake of 364,697 shares — an estimated $1.77M sold.
Lyon Street Capital first reported a position in NEOS in Q3 2017 and held it in 5 quarters. The position peaked at $12.1M in Q1 2018. 62 funds tracked by Wall St. Rank hold NEOS as of Q4 2018.
- Lyon Street Capital reported no remaining Neos Therapeutics position as of Q4 2018 after selling out during the quarter.
- Lyon Street Capital sold 364,697 Neos Therapeutics shares in Q4 2018, an estimated $1.77M.
- Lyon Street Capital first reported a position in Neos Therapeutics in Q3 2017 and held it in 5 quarters.
- Lyon Street Capital's Neos Therapeutics position peaked at $12.1M in Q1 2018.
- 62 funds tracked by Wall St. Rank held Neos Therapeutics as of Q4 2018.
Based on Lyon Street Capital's 13F filing for Q4 2018, filed 14 Feb 2019.